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ABSTRACT: The membrane potential-generating transporters CitP of Leuconostoc mesenteroides and MleP
of Lactococcus lactis are homologous proteins with 48% identical residues that catalyze citrate-lactate
and malate-lactate exchange, respectively. The two transporters are highly specific for substrates containing
a 2-hydroxycarboxylate motif (HO-CR2-COO-) in which substitutions of the R groups are tolerated well.
Differences in substrate specificity between MleP and CitP are based on subtle changes in the interaction
of the protein with the R groups affecting both binding and translocation properties. The conserved, 46-
residue long C-terminal region of the transporters containing the C-terminal putative transmembrane segment
XI was investigated for its role in substrate recognition by constructing chimeric transporters. Replacement
of the C-terminal region of MleP with that of CitP and vice versa did not alter the exchange kinetics with
the substrates malate and citrate, indicating that the main interactions between the proteins and di- and
tricarboxylate substrates were not altered. In contrast, the interaction of the proteins with the
monocarboxylate substrates mandelate and 2-hydroxyisovalerate changed in a complementary manner.
The affinity of CitP for the S-enantiomers of these substrates was at least 1 order of magnitude lower
than observed for MleP. Introduction of the C-terminal residues of MleP in CitP resulted in a higher
affinity and vice versa. Interchanging the C-termini had a more complicated effect on the R-enantiomers,
affecting different kinetic parameters with different substrates, indicating multiple interactions of the R
groups at this side of the binding pocket. It is suggested that the binding pocket is located between
transmembrane segment XI and the other transmembrane segments of the transporters.
The homologous citrate and malate transporters CitP and
MleP found in the lactic acid bacteria Leuconostoc me-
senteroides (1, 2) and Lactococcus lactis (3, 4) function in
secondary metabolic energy-generating pathways. The trans-
porters catalyze the uptake of a substrate into the cell coupled
to the exit of a metabolic end product (precursor-product
exchange; for a review, see ref 5). CitP exchanges divalent
citrate and MleP divalent malate for monovalent lactate, an
end product of both citrate and malate degradation in lactic
acid bacteria (4, 6). Net charge movement over the membrane
during exchange results in a membrane potential of physi-
ological polarity. This, in combination with the generation
of a pH gradient across the membrane due to the consump-
tion of a cytoplasmic proton during the breakdown of citrate
and malate, results in a proton motive force, and thus, the
pathways generate metabolic energy for the cell. More
recently, the pathways have been implicated in the recovery
from acidic stress and resistance against lactate toxicity (7).
The substrates of CitP and MleP are structurally related
(see Figure 1). The ability to exchange citrate or malate for
lactate is associated with a high specificity for the 2-hy-
droxycarboxylate motif present in the substrates, i.e., HO-
CR2-COO-, together with a low specificity for the two R
groups (3). Next to the physiological substrates, CitP and
MleP translocate a wide range of 2-hydroxycarboxylates with
R groups ranging from hydrogen atoms in glycolate to a
phenyl group in mandelate (3). A detailed kinetic analysis
of the two transporters with different substrates showed that
interactions with the OH and COO- groups of the motif are
essential for binding. The interactions with the two R groups
(defined as RR and RS; see Figure 1) are not essential but
modulate affinity and translocation efficiency (8). The
tolerance toward the R groups gives the transporters their
membrane potential-generating capacity. Two types of
interactions take place between the R groups and the binding
sites of CitP and MleP, depending on the nature of the R
group (8). A strong, possibly electrostatic interaction results
in high affinity for 2-hydroxycarboxylates bearing an ad-
ditional carboxylate group at RS (see Figure 1). For example,
the S-enantiomer of malate is a high-affinity substrate.
Noncharged R groups have a less strong, most likely
hydrophobic interaction with the binding site, resulting in
low affinity for monocarboxylates, like lactate.
The difference in substrate recognition by CitP and MleP
is caused by subtle differences in the interactions with the
R groups of the substrates. Most prominent are (i) the
difference in affinity between the mono- and dicarboxylates
which is 1 order of magnitude higher for CitP than for MleP
and (ii) CitP is more promiscuous in the translocation step
toward larger R groups than MleP. The latter feature is
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transporters as citrate and malate transporters; CitP translo-
cates both citrate and malate, while MleP translocates malate
but cannot translocate the larger citrate molecule.
CitP and MleP are 48% identical in their amino acid
sequences and belong to the 2-hydroxycarboxylate transporter
(2-HCT)1 family (3). The membrane topology model of these
transporters consists of 11 transmembrane segments (TMS),
based upon studies of the citrate transporter CitS of Klebsiella
pneumoniae, which also belongs to the 2-HCT family (9-
11). The C-terminal part of the amino acid sequences of the
members of the 2-HCT family, including TMS XI and part
of the cytoplasmic loop between TMS X and XI, is
particularly well conserved. Since the main interactions with
the substrates are very similar for CitP and MleP (8), this
suggests that structural elements involved in substrate binding
may be located in this part of the proteins (3). In the study
presented here, we have constructed chimeric CitP-MleP
transporters in which the conserved C-terminal parts of the
proteins were interchanged. The chimeras were analyzed for
their catalytic properties with 2-hydroxycarboxylate sub-
strates bearing different R groups to locate the interactions
between the proteins and the functional groups of the
substrates in the C- or N-terminal part of the chimeras. The
results suggest that the 46 C-terminal residues of MleP and
CitP contain structural elements that interact with the R
groups of the substrates.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions. L. lactis strain
NZ9000 is a MG1363 derivative (pepN::nisRnisK; 12) that
transports neither citrate nor malate. The nisR and nisK genes
were inserted into the chromosome to allow induced expres-
sion of plasmid-encoded citrate and malate transporters under
control of the tightly regulated nisA promoter (12). Cells were
grown at 30 °C in closed serum bottles and without shaking.
The growth medium contained M17 broth (Difco) supple-
mented with 0.5% (w/v) glucose and 5 íg/mL chloram-
phenicol. Cells were induced by adding supernatant of the
nisin-producing L. lactis strain NZ9700 (13), containing
approximately 10 ng of nisin A/mL (14), to the cultures at
an OD660 of 0.6. Typically, a 1000-fold dillution of the
supernatant was added after which growth was continued
for 1 h followed by harvesting of the cells by centrifugation.
In some cases, a lower level of induction was used to allow
kinetic analysis (see the Results). Then, cells expressing CitP,
MleP, and MC397 were grown in the presence of a 30000-,
50000-, and 30000-fold dillution of the nisin-containing
supernatant, respectively, for 0.5 h.
Construction of Expression Vectors and Chimeras. General
procedures for cloning and DNA manipulations were per-
formed essentially as described by Sambrook et al. (15).
Ligation mixtures were transformed to L. lactis NZ9000
using an electroporation protocol described by Holo and Nes
(16). Expression vector pGltThis (17) encodes the glutamate
transporter of Bacillus stearothermophilus, with an N-
terminal extension of six histidine residues (His tag) followed
by an enterokinase proteolytic cleavage site. The coding
region was amplified by the polymerase chain reaction
1 Abbreviations: 2HCT, 2-hydroxycarboxylate transporter; RSO,
right-side-out; TMS, transmembrane segment; OD660, optical density
at 660 nm; PCR, polymerase chain reaction; SDS-PAGE, sodium
dodecyl sulfate-polyacrylamide gel electrophoresis.
FIGURE 1: Model of the substrate binding site and structure of substrates of CitP and MleP. Sites on the proteins interacting with the
essential OH and COO- groups of the 2-hydroxycarboxylate motif are depicted as gray surfaces. The interaction site responsible for high-
affinity binding of di- and tricarboxylates is depicted as a hatched surface. The two R groups are termed RR and RS according to the
position of the R group in the R- and S-enantiomers of monosubstituted 2-hydroxycarboxylates (HO-CHR-COO-), respectively. At the
right are chemical structures of the substrates used in this study: malate, citrate, lactate, mandelate, and 2-hydroxyisovalerate. The
2-hydroxycarboxylate motif is bold.
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GTCGCATCACCATCACCATCACCATCACCATCACG-
3¢), containing an AflIII restriction site (bold) and 10 histidine
codons (underlined), and a reverse primer downstream of
the stop codon, containing an XbaI site (17). The AflIII-
XbaI-digested PCR product was ligated into the NcoI-XbaI
sites of the nisin inducible expression vector pNZ8048 (CmR,
pSH71 replicon, inducible nisA promoter; O. Kuipers,
unpublished), yielding pNZgltT. Successful ligation destroys
the NcoI site at this position. Subsequently, the gltT gene
was removed, using the NcoI site just downstream of the
enterokinase site (15) and the XbaI site downstream of the
stop codon, and replaced with the citP and mleP genes
containing NcoI-XbaI fragments from plasmids pMBcitP
and pMBmleP that were described previously (3). The
resulting expression vectors, pNZcitP and pNZmleP, encode
the CitP and MleP transporter, respectively, extended with
a 10-His tag and an enterokinase site at the N-terminus. The
amino acid sequences of the N-terminal parts of CitP and
MleP were MSHHHHHHHHHHDDDDKAMVNHP... and
MSHHHHHHHHHHDDDDKAMGKKLK..., respectively,
in which original residues are bold and the enterokinase site
is underlined.
Chimeric transporters were constructed in two steps by
overlap extension PCR (18) using the pNZmleP and pNZcitP
vectors as templates. The PCR products encoding the
chimeric proteins were cloned into the NcoI-XbaI sites of
pNZ8048 in the same way as described above for the wild-
type genes. All constructs were verified by nucleotide
sequencing.
Preparation of Membrane Vesicles and Exchange and
Counterflow Assays. L. lactis NZ9000 cells expressing wild-
type or chimeric transporters were cooled on ice and washed
twice with 50 mM potassium phosphate (pH 6). Right-side-
out (RSO) membrane vesicles were prepared by the osmotic
shock lysis procedure essentially as described previously (8).
Membrane vesicles were washed once in 50 mM potassium
phosphate (pH 6) containing 5 mM (S)-malate and concen-
trated by centrifugation for 15 min in an Eppendorf tabletop
centrifuge operated at full speed, followed by resuspension
in the same buffer. For exchange measurements, the internal
pool of (S)-malate was labeled with (S)-[14C]malate by
incubating the concentrated membranes with 186.7 íM
L-[1,4(2,3)14C]malate for1ha troom temperature in the
presence of 100 íM valinomycin and 50 íM nigericin.
Aliquots (2 íL) were diluted into 200 íLo f5 0m M
potassium phosphate (pH 6) containing various substrates
at the indicated concentrations and at 20 °C. For counterflow
experiments, the (S)-malate-loaded concentrated vesicles
were diluted 100-fold into 200 íL of buffer containing 9.8
íM L-[1,4(2,3)14C]malate and different concentrations of
various substrates when indicated. Final membrane protein
concentrations in the assays were between 250 and 350 íg/
mL. Reactions were stopped at the indicated times by
addition of 4 mL of ice-cold 0.1 M LiCl, followed by rapid
filtration over 0.45 ím pore size cellulose nitrate filters
(Schleicher & Schuell). The filters were rinsed once with
buffer and transferred to scintillation vials to determine the
amount of retained radioactivity. Protein concentrations were
determined as described by Lowry et al. (19).
EValuation of the Data. Initial rates of exchange were
determined by fitting the data to an exponential decay as
described previously (3) using nonlinear fitting procedures
provided with Sigma Plot (Jandel Scientific, San Rafael, CA).
Exchange rates were determined at different external sub-
strate concentrations. The affinity constant (Km) for the
substrate was determined by fitting the data to an equation
describing competitive inhibition that takes into account the
concentration of (S)-[14C]malate in the external buffer caused
by the dilution of the (S)-malate-loaded vesicles (see ref 8).
Initial rates of counterflow were estimated from internalized
label measured in triplicate at 2 and 4 s. Data were used
only when the rate of uptake increased in proportion with
time to ensure initial rate conditions. Inhibition of (S)-malate
counterflow by a substrate was assessed at different con-
centrations of the substrate in the external buffer. The
inhibition constant (Ki) for the substrate was estimated as
described previously (8) by fitting the data to an equation
describing competitive inhibition. When the affinity for the
substrate was low, Ki values were estimated from a single
concentration of 20 mM measured at least in triplicate. A
lower limit for the Ki was calculated when the extent of
inhibition was less than 10%. A Km for exchange or a Ki for
counterflow was determined, depending on the transport
properties of the substrate (8).
SDS-PAGE and Immunoblot Analysis. Right-side-out
membrane vesicles (15 íg of protein/lane) were subjected
to SDS-PAGE using a 12% polyacrylamide gel matrix.
Following electrophoresis, the proteins were transferred to
poly(vinylidene difluoride) membranes and analyzed using
monoclonal antibodies directed against a His tag (Dianova,
Hamburg, Germany). Antibodies were visualized using the
Western-light chemiluminesence detection kit (Trophix,
Bedford, MA).
Materials. L-[1,4(2,3)-14C]Malic acid (51 mCi/mmol) and
[1,5-14C]citric acid (115 mCi/mmol) were obtained from
Amersham International (Buckinghamshire, U.K.). All other
compounds were obtained from Fluca (Buchs, Switzerland)
or Sigma (St. Louis, MO).
RESULTS
Construction of Chimeric Transporters. Figure 2 shows a
multiple-sequence alignment of the C-terminal part of the
members of the 2-hydroxycarboxylate transporter family
together with a topology model. To evaluate the involvement
of the conserved C-terminal part of the CitP and MleP
transporters in substrate binding, four chimeric transporters
(CM397, CM353, MC397, and MC353) were constructed.
Capitals indicate the origin of the N- and C-terminal parts
of the chimera (C for CitP and M for MleP), and the number
indicates the position of the amino acid residue preceding
the junction (CitP numbering). Thus, CM397 consists of the
397 N-terminal residues of CitP and the 46 C-terminal
residues of MleP, whereas the complementary chimera
MC397 consists of the corresponding N-terminal part of
MleP followed by the C-terminal residues of CitP. Wild-
type and chimeric transporters were expressed in L. lactis
NZ9000 cells under control of the inducible nisA promoter
(12). The expression vectors differed only in the coding
sequences of the transporter proteins. Wild-type and chimeric
transporters were tagged with 10 histidine residues at the
N-terminus to allow analysis of expression levels (see
Experimental Procedures).
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expression levels of wild-type and chimeric transport proteins
in L. lactis NZ9000 cells were analyzed by Western blotting
using antibodies raised against the His tag (Figure 3). MleP
runs as a protein with an apparent molecular mass of around
35 kDa, while CitP runs at approximately 40 kDa (lanes 1
and 4). The level of expression of MleP was significantly
higher than that observed for CitP. The apparent molecular
masses of the chimeras correlated with the transporter that
donated the N-terminal part of the sequence, i.e., the residues
responsible for the different mobilities of CitP and MleP on
SDS-PAGE are located in the 353 N-terminal residues. The
level of expression of the chimeras was considerably lower
than that observed for the wild-type proteins and dropped
dramatically when the junction was more toward the N-
terminus in CM353 and MC353. Again, expression levels
of the chimeras seem to be related to the N-terminal
sequences since the level of expression of the MC chimeras
was higher than that observed for the corresponding CM
chimeras (compare lanes 2 and 3 and lanes 5 and 6,
respectively).
(S)-Malate Transport ActiVity. (S)-Malate is a high-affinity
substrate of both CitP and MleP (3). The chimeric transport-
ers were assayed for their ability to catalyze homologous
(S)-malate counterflow and equilibrium exchange. In coun-
terflow, right-side-out membranes prepared from cells ex-
pressing the wild-type or chimeric proteins were loaded with
5m M( S)-malate and, subsequently, diluted 100-fold into
buffer containing 9.8 íM 14C-labeled (S)-malate. The
gradients of labeled and unlabeled (S)-malate over the
membrane drive the label into the lumen of the vesicles via
exchange catalyzed by the transporters (3). The initial rates
of counterflow in membranes containing wild-type CitP and
MleP were very similar (Figure 4A, b and O). Since the
membranes used in these experiments were the same as those
used for the immunoblots shown in Figure 3, it follows that
the specific activity of MleP is lower than the specific activity
of CitP under these conditions. The initial rate of counterflow
of the MC397 chimeric transporter was somewhat lower than
that observed for the wild-type proteins, while the comple-
mentary CM397 transporter exhibited a g10-fold lower
activity. These reductions correlate with the reduced level
of expression of the chimeric proteins when compared to
MleP and CitP. No significant counterflow activity was
observed for the MC353 and CM353 proteins.
Similar observations were made for equilibrium exchange
(Figure 4B). In equilibrium exchange, right-side-out mem-
branes were loaded with 5 mM 14C-labeled (S)-malate and,
FIGURE 2: Amino acid sequence alignment (A) and topology model (B) of the C-terminal part of representative members of the 2-HCT
family. (A) Transporters included in the alignment were the citrate transporter of L. mesenteroides CitPlm (2), the malate transporter of L.
lactis MlePll (3), the citrate transporter of K. pneumoniae CitSkp (23), the malate transporter of Streptococcus boVis MalPsb (24), and two
open reading frames found on the Bacillus subtilis chromosome, YufRbs and YxkJbs (25). Horizontal bars indicate putative TMSs. Arrows
indicate fusion points in the chimeric proteins. Identical residues and similar residues are represented with * and , respectively. Residues
that are conserved in the majority of the transporters are in black boxes. (B) Topology model of the C-terminal part of CitP based on recent
topology studies of CitSkp (9-11).
FIGURE 3: Expression levels of wild-type and chimeric transporters.
Immunoblot of RSO membrane vesicles prepared from L. lactis
NZ9000 expressing the 10-His-tagged MleP (lane 1), MC397 (lane
2), MC353 (lane 3), CitP (lane 4), CM397 (lane 5), and CM353
(lane 6). Indicated on the right are the molecular mass markers.
13062 Biochemistry, Vol. 39, No. 42, 2000 Bandell and Lolkemasubsequently, diluted 100-fold in buffer containing the same
concentration of unlabeled (S)-malate. Exchange catalyzed
by the transporters results in depletion of the radio label in
the lumen of the vesicles. CitP and MleP and the MC397
chimeric protein exhibited very high and similar exchange
rates, while the exchange rate of the CM397 transporter was
significantly lower. No exchange activity could be detected
for the MC353 and CM353 proteins.
The affinity of the transporters for external (S)-malate was
determined by measuring the exchange and/or counterflow
activity at a range of external (S)-malate concentrations. Since
no exchange or counterflow activity was observed for CM353
and MC353, these chimeras were excluded from further
studies. Under standard expression conditions, exchange and
counterflow were too fast to measure initial rates in
membranes containing CitP, MleP, and MC397 (see Figure
4). To allow kinetic analysis of these transporters, expression
levels and thus the initial rates were reduced by manipulating
the inducer concentration in the growth medium and the
induction time. Affinity constants for external (S)-malate
were found to be 0.47 and 0.084 mM for MleP and CitP,
respectively (Table 1), similar to what has been reported
previously for CitP and MleP without the N-terminal His
tags (8). The affinity of CM397 for (S)-malate was not
significantly different from the affinity of CitP, and similarly,
the affinity of MC397 was very close to the affinity of MleP.
In conclusion, the activities of the chimeric proteins with
(S)-malate as the substrate correlate with the levels of
expression of the proteins, and the affinities of the CM397
and MC397 chimeras appear to be determined by the
N-terminal parts of the chimeras.
Specificity for Citrate. CitP translocates citrate with high
efficiency, while MleP is unable to translocate citrate, but
still binds citrate with low affinity (8). The affinity of the
transporters for external citrate was measured by substituting
(S)-malate in the dilution buffer in the exchange assay for
citrate (heterologous exchange) or by assessing the inhibition
of (S)-malate counterflow by external citrate. When corrected
for the external (S)-malate concentration, the affinity constant
for heterologous exchange and the inhibition constant for
counterflow represent the same kinetic parameter (for a
discussion, see ref 8). The affinity constant of CitP for
external citrate in the heterologous exchange reaction was
0.056 mM, while the inhibition constant of citrate for MleP-
catalyzed counterflow was 9 mM (Table 1). Chimera CM397
effectively exchanged (S)-malate for citrate with an affinity
constant for external citrate that was similar to that observed
for CitP (Table 1). The complementary chimera MC397 was
unable to translocate citrate (not shown), but citrate inhibited
(S)-malate counterflow with an inhibition constant of 8.7
mM, as was observed for MleP. In conclusion, the structural
elements enabling CitP to translocate citrate seem to be
located outside the 46 C-terminal amino acids.
Specificity for Monocarboxylates. The results described
above indicate that interchanging the 46 C-terminal amino
acid residues of CitP and MleP altered neither the specificity
nor the affinity for the di- and tricarboxylates malate and
citrate. In contrast, changes in substrate specificity were
observed with monocarboxylates. Mandelate is a 2-hydroxy-
carboxylate in which the two R groups are a hydrogen atom
and a phenyl group (Figure 1). (S)-Mandelate at a concentra-
tion of 5 mM did not induce release of 14C-labeled (S)-malate
from right-side-out membranes containing CitP, while ex-
change with 5 mM (S)-malate was fast in the same
membranes (Figure 5A). At 20 mM (S)-mandelate, a low-
level but significant exchange was observed, indicating that
CitP could translocate (S)-mandelate (not shown). Replace-
ment of the 46 C-terminal amino acids with the correspond-
ing MleP residues enabled the resulting CM397 chimera to
catalyze heterologous (S)-mandelate-(S)-malate exchange
at a significant rate at 5 mM (S)-mandelate (Figure 5B). The
(S)-malate exchange rate was reduced due to the lower level
of expression of the chimeric transporter. Clearly, the
substrate selectivity of the chimeric transporter had changed.
Under the same conditions, exchange rates for a number of
other monocarboxylates, i.e., (R)-mandelate, (S)- and (R)-
2-hydroxyisovalerate, and (S)- and (R)-lactate, were deter-
Table 1: Affinity Constants of Wild-Type and Chimeric Transporters for External Substrates
CitP CM397 MleP MC397
Ki (mM) Km (mM) Ki (mM) Km (mM) Ki (mM) Km (mM) Ki (mM) Km (mM)
(S)-malate 0.068 ( 0.009 0.10 ( 0.022 0.056 ( 0.015 0.091 ( 0.022 0.47 ( 0.1 0.64 ( 0.09
citrate 0.056 ( 0.009a 0.042 ( 0.009 9 ( 2a 8.5 ( 2
(S)-mandelate >100b 63 ( 5 3.5 ( 0.5 13.5 ( 2
(S)-2-hydroxyisovalerate >150b 28 ( 43 1 ( 5 >350b
(R)-mandelate 7 ( 25 ( 3 4.0 ( 0.8 4.7 ( 0.6
(R)-2-hydroxyisovalerate 12.5 ( 3 3.1 ( 1.9 29 ( 9 102 ( 26
a Ki value taken from ref 8. b Lower limit of Ki values estimated from the inhibition at an external substrate concentration of 20 mM.
FIGURE 4: Homologous (S)-malate counterflow (A) and exchange
(B) by wild-type and chimeric transporters. RSO membrane vesicles
of L. lactis NZ9000 expressing CitP (b), MleP (O), CM397 (2),
MC397 (1), CM353 (9), and MC353 (0) were preloaded with 5
mM (S)-malate and diluted 100-fold into buffer containing 9.8 íM
(S)-[14C]malate (A) or preloaded with 5 mM (S)-[14C]malate and
diluted 100-fold into buffer containing 5 mM (S)-malate (B).
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increase in the relative exchange rates (Figure 6A,B).
Except for (S)- and (R)-lactate, heterologous exchange with
the same compounds catalyzed by MleP was much slower
and significant only for the S-enantiomers of mandelate and
2-hydroxyisovalerate (Figure 6C,D). Heterologous lactate
exchange was similar as observed for MleP without the His
tag (8). Introducing the 46 C-terminal residues of CitP in
MleP yielding MC397 resulted in the complete loss of
exchange activity with these compounds; i.e., the effect was
the reciprocal of what was observed with the CitP and
CM397 transporters. No change in specificity for (S)- and
(R)-lactate was observed for the MleP and MC397 transport-
ers.
The changes in heterologous exchange activity of the
chimeric proteins observed with the monocarboxylates
reported in Figure 6 do not discriminate between changes
in affinity and changes in translocation efficiency. The
affinities of the transporters for the substrates were measured
as discussed above for citrate. The low rate of exchange
observed for (S)-mandelate and (S)-2-hydroxyisovalerate
catalyzed by CitP was due to the low affinity of the
transporter for these substrates. In fact, the affinity constants
were too high to be measured accurately and were estimated
to be >100 mM for (S)-mandelate and even >150 mM for
(S)-2-hydroxyisovalerate (Table 1). In contrast, the low
exchange rates with these compounds catalyzed by MleP
were due to the lack of translocation; the inhibition constants
for (S)-mandelate and (S)-2-hydroxyisovalerate were 3.5 and
31 mM, respectively. These results reveal an important
difference between CitP and MleP; MleP binds the S-
enantiomers of these two substrates with much higher affinity
than CitP, but CitP translocates them better than MleP. A
similar observation was reported before for the physiological
substrate lactate (8). The R-enantiomers of mandelate and
2-hydroxyisovalerate bound with similar affinities to CitP
and MleP.
The improved exchange observed for (S)-mandelate and
(S)-2-hydroxyisovalerate when the 46 C-terminal residues
of CitP were replaced with the corresponding residues of
MleP was caused by an improved affinity of the CM397
chimera for these substrates (Table 1). The C-terminal
residues of MleP seem to introduce the higher affinity of
MleP for these substrates into the chimera. Most importantly,
the affinity of the complementary chimera MC397 for these
substrates decreased relative to the affinities of MleP for these
substrates. The largest affinity changes were observed for
(S)-2-hydroxyisovalerate for which the affinity increased by
a factor of at least 5 between CitP and CM397 and decreased
by a factor of at least 10 between MleP and MC397 (Figure
7). The chimeras seem to adopt the affinity for the S-
enantiomers of mandelate and 2-hydroxyisovalerate of the
transporter that donated the C-terminus.
FIGURE 5: (S)-Mandelate-(S)-malate exchange catalyzed by CitP
(A) and CM397 (B). RSO membrane vesicles of L. lactis NZ9000
expressing CitP (A) and CM397 (B) were preloaded with 5 mM
(S)-[14C]malate and diluted 100-fold into buffer containing no
further additions (O) ,5m M( S)-malate (b) ,a n d5m M( S)-
mandelate (9).
FIGURE 6: Heterologous exchange catalyzed by the wild-type and chimeric transporters. RSO membrane vesicles of L. lactis NZ9000
expressing CitP (A), CM397 (B), MleP (C), and MC397 (D) were preloaded with 5 mM (S)-[14C]malate and diluted 100-fold into buffer
containing the indicated substrates at 5 mM. Left (white) and right (black) bars correspond to the S- and R-enantiomeric forms of the
substrates, respectively. Rates represent the average of two to four independent measurements and are given relative to the rate observed
for homologous (S)-malate exchange. Error bars represent the standard deviations.
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chimeric proteins were only minor for the R-enantiomer of
mandelate, indicating that the higher heterologous exchanged
rate observed for CM397 relative to that for CitP (Figure
6A,B) was mainly due to an improved translocation ef-
ficiency. In contrast, the affinities for the R-enantiomer of
2-hydroxyisovalerate changed 3-fold and in the opposite
direction for CM397 and MC397. Replacing the C-terminal
residues in CitP resulted in a increase in affinity, while
replacing the same residues in MleP resulted in a decrease
in affinity (Table 1).
DISCUSSION
The malate transporter MleP and the citrate transporter
CitP are homologous proteins with 48% identical amino acid
residues in their primary structure. Both proteins transport
structurally related substrates, and differences in substrate
specificity between MleP and CitP were found to be due to
subtle, but well-defined, differences in binding and/or
translocation properties (8). The conserved nature of the
substrate binding site led us to believe that structural elements
involved in substrate recognition might be located in
conserved stretches of the amino acid residues. The highest
level of sequence conservation in the 2-HCT family is found
in a stretch of 46 residues at the C-terminus. To analyze the
involvement of the C-terminal region in substrate recognition,
we have interchanged the C-terminal stretches between the
two transporters and analyzed the resulting chimeras for
substrate specificity. An advantage of this approach is that
the subtle differences in substrate specificity between CitP
and MleP may depend on a combination of different amino
acid residues at multiple positions which may be difficult to
trace using site-directed mutagenesis.
Activities of the CM397 and MC397 chimeric transporters
with (S)-malate as the substrate were lower than those
observed for the wild-type transporters. The activities cor-
related with the reduced levels of expression of the chimeric
proteins when CM397 was compared to CitP and MC397
to MleP, suggesting that the specific (S)-malate transport
activity remained unchanged upon replacement of the C-
terminal sequences. The loss of expression was dramatic
when the fusion point was moved further to the N-terminus
in chimeras CM353 and MC353 (Figure 3) for which no
exchange activity could be detected. Similar observations
were made with chimeras between CitP and MleP that had
fusion points at positions 256 and 298 (not shown). The
lower expression levels of CM397 and MC397 and the other
chimeras seem unlikely to be due to a loss of structural
integrity and, consequently, degradation of the chimeras. The
chimeric molecules that enter the plasma membrane had the
same kinetic parameters as the parental proteins (see below),
and no breakdown products could be detected in either
membrane vesicles or whole cells expressing the chimeras
(not shown). Interestingly, expression levels of the wild-type
transporters were also found to differ greatly even though
the expression system and the induction and growth condi-
tions were exactly the same.
CitP and MleP transport substrates that present the
2-hydroxycarboxylate motif (HO-CR2-COO-). Previous stud-
ies of the catalytic properties of the two transporters with a
large range of 2-hydroxycarboxylates (3, 8) have resulted
in a model of the substrate binding site that indicates the
interaction between the functional groups of the substrates
and (unknown) groups on the proteins (Figure 1). In the
model, two essential interactions are between groups in the
binding pocket and the carboxylate and hydroxyl groups of
the 2-hydroxycarboxylate motif that is common to all
substrates. These interactions are like anchors that orient the
substrates in the binding pocket. A third, nonessential
anchoring point in the pocket (RS side) interacts with a second
carboxylate group on the substrates. This interaction is
responsible for high-affinity binding of di- and tricarboxylates
with a second carboxylate at RS.( S)-Malate interacts with
the protein via these three interactions. The kinetic parameters
of chimeric proteins CM397 and MC397 with (S)-malate as
the substrate were the same as those observed for the parental
transporters that donated the N-terminal part, indicating that
the spatial arrangement of the three anchoring points on the
proteins was the same as in the parental proteins. The most
straightforward conclusion would be that the entire binding
pocket would be located in the 397 N-terminal residues;
however, the possibility that part of the interacting sites in
the binding pocket are conserved in the 46 C-terminal
residues cannot be excluded. Clearly, the difference in the
affinity of CitP and MleP for (S)-malate is encoded in the
N-terminal part.
The citrate molecule differs from the (S)-malate molecule
in that it has a CH2COOH group instead of a H atom at the
RR position. This carboxylate group is protonated when the
transporters interact with citrate (8). The CitP protein has
no problem in accommodating the group and binds and
transports citrate as efficiently as it does (S)-malate. On the
other hand, MleP has a g10-fold lower affinity for citrate
than for (S)-malate and is unable to translocate citrate. In
this respect, the MC397 chimera behaved exactly like MleP
and the CM397 chimera like CitP, indicating that the
structural elements interacting with the CH2COOH group of
citrate at the RR side of the binding pocket are located in the
N-terminal part of the proteins.
The catalytic properties of CitP and MleP with citrate as
the substrate were also recognized in the activities with
monocarboxylates with a hydrophobic group at the RR side
FIGURE 7: Inhibition of (S)-malate counterflow by (S)-2-hydroxy-
isovalerate. RSO membrane vesicles of L. lactis NZ9000 expressing
(A) CitP (O) and CM397 (0) and (B) MleP (b) and MC397 (9)
were loaded with 5 mM (S)-malate and diluted 100-fold in buffer
containing 9.8 íM( S)-[14C]malate and increasing concentrations
of (S)-2-hydroxyisovalerate. Rates were indicated as the percentage
of the rate observed in the absence of inhibitor. The deduced Ki
values corrected for the external (S)-malate concentration (59.8 íM)
are given in Table 1.
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porters exhibited affinity for the substrates, but as was
observed for citrate, MleP was found to be unable to transport
them [Table 1 (8)]. However, unlike with citrate, replacement
of the 46 C-terminal residues in the two chimeras did affect
the catalytic properties with the R-enantiomers of the
monocarboxylates. Introduction of the C-terminus of MleP
in CitP yielding CM397 resulted in a higher exchange activity
relative to (S)-malate (Figure 6). Kinetic analysis revealed
that the improved activity with (R)-mandelate was caused
by an improved translocation efficiency of CM397 relative
to CitP, while in the case of (R)-2-hydroxyisovalerate, the
affinity of the chimera improved 4-fold (Table 1). The
different mechanisms suggest a different interaction of the
two hydrophobic R groups with the proteins. Importantly,
the affinity for (R)-2-hydroxyisovalerate decreased between
MleP and MC397 by a factor of 3-4, showing that the results
of interchanging the C-terminal sequences were reciprocal.
A reciprocal effect on the translocation efficiency of (R)-
mandelate was undetectable since MleP showed no activity
with (R)-mandelate to begin with. In conclusion, even though
the effects of interchanging the C-terminal residues on the
RR groups of the substrates are not specific and, as such, do
not provide evidence for a direct interaction between the
C-terminal residues and the RR groups of the substrates, the
results do indicate the involvement of the C-terminal region
in catalysis.
The strongest evidence that the 46 C-terminal residues in
CitP and MleP constitute part of the substrate binding pocket
comes from the affinity changes observed for the S-
enantiomers of the monocarboxylates mandelate and 2-hy-
droxyisovalerate that interact with the RS side of the binding
pocket. CitP has very little affinity for these substrates, but
translocates them with high efficiency. In contrast, MleP
binds these substrates with an affinity that is at least 1 order
of magnitude higher, but translocation is very inefficient.
The chimeras CM397 and MC397 adopted specifically the
affinities, not the translocation efficiencies, for (S)-mandelate
and (S)-hydroxyisovalerate from the parent that donated the
C-terminal residues (Table 1 and Figures 6 and 7). Appar-
ently, the C-terminal residues are involved in the initial
recognition of the substrates. Consequently, at concentrations
of 5 mM, heterologous exchange activity with these sub-
strates improves considerably in CM397 and is diminished
in the complementary chimera MC397. Arguments against
long-range conformational effects and in favor of a model
in which the 46 C-terminal residues contain the structural
elements at the RS side of the binding pocket are as follows:
(i) the effects in the two chimeras are reciprocal, (ii) the
chimeras adopt a property of the donor of the C-terminal
sequences, and (iii) the C-terminal sequences specifically
effect the affinity for the substrates.
The model for the membrane topology of CitP and MleP
shows 11 putative transmembrane R-helices with the N-
terminus in the cytoplasm and the C-terminus in the
periplasm. The C-terminal region that in this study was
interchanged between the two transporters consists of TMS
XI that is outgoing and part of the cytoplasmic loop between
TMSs X and XI. This study suggests that the C-terminal
region interacts directly with the hydrophobic RS groups of
the monocarboxylate substrates and, thus, suggests that the
binding site is at the interface of TMS XI and the other TMSs
of the proteins. The hydrophobic groups at the RS side of
the binding pocket seem to interact with similar sites located
on TMS XI since exchange of the C-terminal parts affects
the kinetics with different substrates in a similar manner.
The RR groups of the substrates that are necessarily close in
the binding pocket seem to have a less well-defined interac-
tion with the proteins. In citrate, the polar CH2COOH group
interacts with the N-terminal TMSs while the hydrophobic
R groups of (R)-2-hydroxyisovalerate and (R)-mandelate
sense changes in the C-terminus, but not in the same way.
This interaction of functional groups located in space at the
same side of a substrate molecule with different parts of the
protein is reminiscent of what has been proposed to be the
mechanism by which multidrug transporter proteins interact
with their substrates (20-22). No change in the three
anchoring points that interact with the hydroxyl and car-
boxylate group of the substrate motif and the second
carboxylate at RS was observed in the chimeras, indicating
that their relative localization in the binding pocket is
unchanged. The anchoring points are either in the N-terminal
part or conserved between CitP and MleP in the 46
C-terminal residues. The C-terminal part contains two
conserved arginines, one of which is located in the TMS
XI, that are good candidates for being involved in the
electrostatic interactions with the carboxylate groups of the
substrates. At present, we are mutating these and other
residues to further analyze the role of TMS XI in substrate
recognition.
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